Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRoHerpARD: Acyclovir for Prevention of Recurrent Herpes Simplex in Autoimmune Rheumatic Diseases
NCT07341386Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2026
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of aciclovir in herpes simplex (HSV), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jun 2026; status: recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT07341386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07341386.